Peter P. Pfreundschuh Uro Gen Pharma Ltd. (URGN) insider trading activity

Peter P. Pfreundschuh is Chief Financial Officer of UroGen Pharma Ltd.. Currently has a direct ownership of 10,405 shares of URGN, which is worth approximately $129,854. The most recent transaction as insider was on Oct 15, 2020, when has been sold 2,400 shares (Ordinary Shares) at a price of $21.78 per share, resulting in proceeds of $52,272. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.4K

0% 3M change

0% 12M change

Total Value Held $129,854

PETER P. PFREUNDSCHUH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Oct 15 2020	SELL Open market or private sale	$52,272 $21.78 p/Share	2,400 Reduced 18.74%	10,405 Ordinary Shares
Oct 15 2020	BUY Exercise of conversion of derivative security	-	4,917 Added 27.75%	12,805 Ordinary Shares

Also insider at

FREQ

Frequency Therapeutics, Inc. Healthcare

Chief Financial Officer

VYGR

Voyager Therapeutics, Inc. Healthcare

Chief Financial Officer

YMAB

Y-mAbs Therapeutics, Inc. Healthcare

CFO and Treasurer

PPP